All Content

Press Releases
CAS Releases Special Report Highlighting COVID-19 Diagnostic Test Research
CAS has issued a special report in ACS Central Science titled “Assay Techniques and Test Development for COVID-19 Diagnosis.” This report provides a detailed overview of COVID-19 diagnostic tests, trends, and resources. Read more
Assay Techniques and Test Development for COVID-19 Diagnosis
To provide a better understanding and comparison of the diagnostic tests available in the fight against COVID-19, CAS has produced a report summarizing the basic principles of molecular and serological assays being used in diagnostic tests for SARS-CoV-2. The report highlights recent advancements in testing technologies and provides a high-level view of currently available diagnostic tests. Read more
Case Studies
Curated Training Sets for Innovative AI Predictions
Utilizing only internal data can lead to the lack of specific electronic, structure and device properties required to generate innovative machine learning predictions. Learn how one company turned to custom-curated data to expand a limited view of the scientific landscape. Read more
Getting Started in Data-Driven Chemical and Materials Discovery
Are you just getting started or ramping up machine learning for chemical and materials research? In this webinar, the panelists will discuss how to prepare for a new informatics project by exploring how to build useful data sets, identify missing capabilities, and communicate expectations. Read more
Press Releases
CAS Releases Open Access Dataset of Antiviral Chemical Compounds to Aid COVID-19 Discovery and Analysis
CAS has released an open access dataset of chemical compounds with known or potential antiviral activity to support COVID-19 research and data mining. The dataset contains nearly 50,000 chemical substances assembled from the CAS REGISTRY® that have antiviral activity reported in published literature or are structurally similar to known antivirals. Available to download now. Read more
Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
To support R&D on COVID-19, CAS has produced a special report to provide an overview of published scientific information with an emphasis on patents in the CAS content collection. It highlights antiviral strategies involving small molecules and biologics targeting complex molecular interactions involved in coronavirus infection and replication. The drug-repurposing effort documented herein focuses primarily on agents known to be effective against other RNA viruses including SARS-CoV and MERS-CoV. Read more
Press Releases
CAS and PatSnap Forge Strategic Partnership that Unites Market-leading Scientific Content and AI-powered Technology to Accelerate Global Innovation
This CAS and PatSnap partnership unites market-leading scientific content and AI-powered technology to accelerate global innovation. Collaboration strengthens leading sci-tech information solutions to deliver enhanced insight across R&D and IP workflows. Read more
Hydrogen Fuel - Insights into a Growing Market
Download this in-depth CAS Market Report to gain insight into the evolution of hydrogen fuel technology, the global innovation landscape, key market trends and potential applications and opportunities. Read more
Case Studies
Driving Innovation with Data: Preserving Brazil’s Biodiversity
In this case study, learn how CAS collaborated with natural product researchers in Brazil to build an accessible data collection, representing over 54,000 substances from Brazilian biodiversity. Read more